60 related articles for article (PubMed ID: 24767862)
1. BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis.
Cornejo KM; Hutchinson L; Deng A; Tomaszewicz K; Welch M; Lyle S; Dresser K; Cosar EF
Hum Pathol; 2014 Jun; 45(6):1213-20. PubMed ID: 24767862
[TBL] [Abstract][Full Text] [Related]
2. Additional loss of MSH2 and MSH6 expression in sporadic deficient mismatch repair colorectal cancer due to MLH1 promoter hypermethylation.
Westwood A; Glover A; Hutchins G; Young C; Brockmoeller S; Robinson R; Worrilow L; Wallace D; Rankeillor K; Adlard J; Quirke P; West N
J Clin Pathol; 2019 Jun; 72(6):443-447. PubMed ID: 30723092
[TBL] [Abstract][Full Text] [Related]
3. Mismatch Repair (MMR) Gene Alteration and BRAF V600E Mutation Are Potential Predictive Biomarkers of Immune Checkpoint Inhibitors in MMR-Deficient Colorectal Cancer.
Sahin IH; Goyal S; Pumpalova Y; Sonbol MB; Das S; Haraldsdottir S; Ahn D; Ciombor KK; Chen Z; Draper A; Berlin J; Bekaii-Saab T; Lesinski GB; El-Rayes BF; Wu C
Oncologist; 2021 Aug; 26(8):668-675. PubMed ID: 33631043
[TBL] [Abstract][Full Text] [Related]
4. Muir-Torre syndrome and recent updates on screening guidelines: The link between colorectal tumors and sebaceous adenomas in unusual locations.
Shaker N; Shaker N; Abid A; Shah S; Shakra RA; Sangueza OP
J Surg Oncol; 2023 Dec; 128(8):1380-1384. PubMed ID: 37706607
[TBL] [Abstract][Full Text] [Related]
5. Patients with a new-onset cutaneous sebaceous neoplasm following immunosuppression should be evaluated for Muir-Torre syndrome with germline mismatch repair gene mutation analysis: case reports.
Cohen PR; Kurzrock R
Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762859
[TBL] [Abstract][Full Text] [Related]
6. BRAF(V600E) efficient transformation and induction of microsatellite instability versus KRAS(G12V) induction of senescence markers in human colon cancer cells.
Oikonomou E; Makrodouli E; Evagelidou M; Joyce T; Probert L; Pintzas A
Neoplasia; 2009 Nov; 11(11):1116-31. PubMed ID: 19881948
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemistry, Molecular Biology, and Clinical Scoring for the Detection of Muir-Torre Syndrome in Cutaneous Sebaceous Tumors: Which Strategy?
Sinson H; Karayan-Tapon L; Godet J; Rivet P; Alleyrat C; Battistella M; Pierron H; Morel F; Lecron JC; Favot L; Frouin E
Dermatology; 2023; 239(6):889-897. PubMed ID: 37717564
[TBL] [Abstract][Full Text] [Related]
8. Assessing Mismatch Repair Expression by Immunohistochemistry in Colorectal Adenocarcinoma -Insight from a Tertiary Care Centre.
Lakhe R; Doshi R; Doshi P; Patil A; Nimbargi R
Gulf J Oncolog; 2024 May; 1(45):35-41. PubMed ID: 38774931
[TBL] [Abstract][Full Text] [Related]
9. Sebaceous carcinoma epidemiology, associated malignancies and Lynch/Muir-Torre syndrome screening in England from 2008 to 2018.
Cook S; Pethick J; Kibbi N; Hollestein L; Lavelle K; de Vere Hunt I; Turnbull C; Rous B; Husain A; Burn J; Lüchtenborg M; Santaniello F; McRonald F; Hardy S; Linos E; Venables Z; Rajan N
J Am Acad Dermatol; 2023 Dec; 89(6):1129-1135. PubMed ID: 37031776
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of lynch syndrome (DNA mismatch repair protein deficiency) in patients with primary localized prostate cancer using immunohistochemistry screening.
Oka S; Urakami S; Hagiwara K; Hayashida M; Sakaguchi K; Miura Y; Inoshita N; Arai M
Hered Cancer Clin Pract; 2023 Oct; 21(1):20. PubMed ID: 37828628
[TBL] [Abstract][Full Text] [Related]
11. NGS Analysis Confirms Common
Peterson C; Moore R; Hicks JL; Morsberger LA; De Marzo AM; Zou Y; Eberhart CG; Campbell AA
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445161
[TBL] [Abstract][Full Text] [Related]
12. BRAF
Grillo F; Paudice M; Pigozzi S; Dono M; Lastraioli S; Lugaresi M; Bozzano S; Tognoni C; Ali M; Sciallero S; Puccini A; Fassan M; Mastracci L
Histopathology; 2024 Apr; 84(5):877-887. PubMed ID: 38173291
[TBL] [Abstract][Full Text] [Related]
13. Sebaceomas in a Muir-Torre-like Phenotype in a Patient with MUTYH-Associated Polyposis.
Guarrera J; Prezzano JC; Mannava KA
Dermatopathology (Basel); 2024 Mar; 11(1):124-128. PubMed ID: 38534264
[TBL] [Abstract][Full Text] [Related]
14. Artificial Intelligence in Predicting Microsatellite Instability and KRAS, BRAF Mutations from Whole-Slide Images in Colorectal Cancer: A Systematic Review.
Guitton T; Allaume P; Rabilloud N; Rioux-Leclercq N; Henno S; Turlin B; Galibert-Anne MD; Lièvre A; Lespagnol A; Pécot T; Kammerer-Jacquet SF
Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201408
[TBL] [Abstract][Full Text] [Related]
15. Extendable blocking probe in reverse transcription for analysis of RNA variants with superior selectivity.
Ho TH; Dang KX; Lintula S; Hotakainen K; Feng L; Olkkonen VM; Verschuren EW; Tenkanen T; Haglund C; Kolho KL; Stenman UH; Stenman J
Nucleic Acids Res; 2015 Jan; 43(1):e4. PubMed ID: 25378315
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations.
Kim YS; Park GS; Chung YJ; Lee JH
J Dermatol; 2023 Aug; 50(8):1072-1075. PubMed ID: 36938660
[TBL] [Abstract][Full Text] [Related]
17. Sebaceous Neoplasm With Defective DNA Mismatch Repair.
Tekin B; Gupta S; Erickson LA
Mayo Clin Proc; 2024 May; 99(5):846-848. PubMed ID: 38702131
[No Abstract] [Full Text] [Related]
18. Giant syringocystadenocarcinoma papilliferum with conjunctival recurrence: Possible Schimmelpenning syndrome with postzygotic G13R HRAS and K601N BRAF signature.
Dupont A; Vergara R; Pacaud A; Dequidt L; Dutriaux C; Saunier V; Caumont C; Jullie ML; Taïeb A; Morice-Picard F; Dousset L
J Eur Acad Dermatol Venereol; 2023 Dec; 37(12):e1420-e1422. PubMed ID: 37458522
[No Abstract] [Full Text] [Related]
19. Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome.
Lamba AR; Moore AY; Moore T; Rhees J; Arnold MA; Boland CR
Fam Cancer; 2015 Jun; 14(2):259-64. PubMed ID: 25637498
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
